Skip to main content

Table 4 Estimated year survival rates (1, 3, 5, and 10) in patients with pCR, stratified by adjuvant chemotherapy in the FUSCC

From: Adjuvant chemotherapy for rectal cancer with complete pathological response (pCR) may not be necessary: a pooled analysis of 5491 patients

Survival

No chemo

Chemotherapy

Overall survival (patients at risk)

 1-year rate

94.5 ± 3.1 (56)

98.8 ± 1.2 (115)

 3-year rate

94.5 ± 3.1 (22)

94.6 ± 1.2 (53)

 5-year rate

94.5 ± 3.1 (7)

92.8 ± 3.1 (22)

 10-year rate

94.5 ± 3.1 (1)

92.8 ± 3.1 (1)

Disease-free survival (patients at risk)

 1-year rate

91.1 ± 3.8 (56)

93.8 ± 2.3 (115)

 3-year rate

88.8 ± 4.3 (20)

92.8 ± 2.5 (49)

 5-year rate

88.8 ± 4.3 (6)

87.5 ± 3.5 (21)

 10-year rate

88.8 ± 4.3 (0)

87.5 ± 3.5 (0)